RhumbLine Advisers’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,384	Closed	-$184K	–	3028
2019 Q1	$184K	Buy	4,384 +191	+5%	+$8.02K	﹤0.01%	2766
2018 Q4	$174K	Buy	4,193 +1,656	+65%	+$68.7K	﹤0.01%	2775
2018 Q3	$122K	Buy	+2,537	New	+$122K	﹤0.01%	2841